NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Mechanistically, resveratrol reversed the methylation status of the Nrf2 promoter in NAFLD mouse model and in HepG2 cells treated by high glucose, demethylated Nrf2-promoted Nrf2 and Nrf2-controlled antioxidant gene transcription, and inhibited ROS generation [65].